EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

A physiological approach to renal clearance: From premature neonates to adults

Nick Holford iD, Conor J O'Hanlon iD, Karel Allegaert, Brian Anderson, Amilcar Falcão, Nicolas Simon, Yoke-Lin Lo iD, Alison H Thomson iD, Catherine M Sherwin iD, Evelyne Jacqz-Aigrain iD, Carolina Llanos-Paez, Stefanie Hennig iD und 2 weitere

British Journal of Clinical Pharmacology · 2024-04 · 90 (4) · 1066-1080

DOI: 10.1111/bcp.15978 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Clinical Pharmacology, online erschienen am 17.01.2024. Verfasst von Nick Holford und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology & Clinical Pharmacology, University of Auckland, Auckland, New Zealand. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Vancomycin. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

We propose using glomerular filtration rate (GFR) as the physiological basis for distinguishing components of renal clearance.

Methods

Gentamicin, amikacin and vancomycin are thought to be predominantly excreted by the kidneys. A mixed‐effects joint model of the pharmacokinetics of these drugs was developed, with a wide dispersion of weight, age and serum creatinine. A dataset created from 18 sources resulted in 27,338 drug concentrations from 9,901 patients. Body size and composition, maturation and renal function were used to describe differences in drug clearance and volume of distribution.

Results

This study demonstrates that GFR is a predictor of two distinct components of renal elimination clearance: (1) GFR clearance associated with normal GFR and (2) non‐GFR clearance not associated with normal GFR. All three drugs had GFR clearance estimated as a drug‐specific percentage of normal GFR (gentamicin 39%, amikacin 90% and vancomycin 57%). The total clearance (sum of GFR and non‐GFR clearance), standardized to 70 kg total body mass, 176 cm, male, renal function 1, was 5.58 L/h (95% confidence interval [CI] 5.50‐5.69) (gentamicin), 7.77 L/h (95% CI 7.26‐8.19) (amikacin) and 4.70 L/h (95% CI 4.61‐4.80) (vancomycin).

Conclusions

GFR provides a physiological basis for renal drug elimination. It has been used to distinguish two elimination components. This physiological approach has been applied to describe clearance and volume of distribution from premature neonates to elderly adults with a wide dispersion of size, body composition and renal function. Dose individualization has been implemented using target concentration intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsVancomycinInfant, NewbornAdultHumansMaleAgedAmikacinGentamicinsGlomerular Filtration RateMetabolic Clearance RateCreatinine

Stichwörter der Autor:innen

amikacinclinical pharmacologygentamicininfectious diseasesnephrologypaediatricspharmacometricsvancomycin

Substanzen

Anti-Bacterial AgentsVancomycinAmikacinGentamicinsCreatinine

Autor:innen und Institutionen

  • Department of Pharmacology & Clinical Pharmacology, University of Auckland, Auckland, New Zealand.
  • Department of Development and Regeneration, KU Leuven, Leuven, Belgium.
  • Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.
  • Department of Hospital Pharmacy, Erasmus MC, Rotterdam, The Netherlands.
  • Department of Anaesthesiology, University of Auckland, Auckland, New Zealand.
  • Faculty of Pharmacy, Coimbra Institute for Biomedical Imaging and Translational Research, University of Coimbra, Coimbra, Portugal.

ORCID-Profile: Nick Holford, Conor J O'Hanlon, Yoke-Lin Lo, Alison H Thomson, Catherine M Sherwin, Evelyne Jacqz-Aigrain, Stefanie Hennig, Carl Kirkpatrick

Zitieren

APA

Holford, N., O'Hanlon, C. J., Allegaert, K., Anderson, B., Falcão, A., Simon, N., Lo, Y. L., Thomson, A. H., Sherwin, C. M., Jacqz-Aigrain, E., Llanos-Paez, C., Hennig, S., Mockus, L., & Kirkpatrick, C. (2024). A physiological approach to renal clearance: From premature neonates to adults. British Journal of Clinical Pharmacology, 90(4), 1066-1080. https://doi.org/10.1111/bcp.15978

Vancouver

Holford N, O'Hanlon CJ, Allegaert K, Anderson B, Falcão A, Simon N, et al. A physiological approach to renal clearance: From premature neonates to adults. British Journal of Clinical Pharmacology. 2024;90(4):1066-1080. doi:10.1111/bcp.15978

BibTeX
@article{Holford2024,
  author = {Holford, Nick and O'Hanlon, Conor J and Allegaert, Karel and Anderson, Brian and Falcão, Amilcar and Simon, Nicolas and Lo, Yoke-Lin and Thomson, Alison H and Sherwin, Catherine M and Jacqz-Aigrain, Evelyne and Llanos-Paez, Carolina and Hennig, Stefanie and Mockus, Linas and Kirkpatrick, Carl},
  title = {A physiological approach to renal clearance: From premature neonates to adults},
  journal = {British Journal of Clinical Pharmacology},
  year = {2024},
  volume = {90},
  number = {4},
  pages = {1066--1080},
  doi = {10.1111/bcp.15978}
}
Kostenlos starten →